铁素功能化的黑纳米平台使得动脉硬化斑块的向和长时间的MRI可视化成为可能
Xiao Huang1,2, Yuanyuan Zhao1,2, Miao Zhou1,2
1Institute of Pharmaceutical Innovation, Hubei Province Key Laboratory of Occupational Hazard Identification and Control, School of Medicine, Wuhan University of Science and Technology, Wuhan, 430065, China.
概括
一个新的2D黑色纳米平台,FcP,增强MRI对比度用于心血管诊断. 这种稳定,向的药物可提供动脉样硬化病变的长期可视化,具有出色的生物安全性.
科学领域:
- 材料科学 材料科学 材料科学
- 纳米技术纳米技术
- 生物医学工程 生物医学工程
背景情况:
- 增强对比度的MRI对于诊断至关重要,但当前的药物存在安全性和稳定性问题.
- 金属剂引发生物安全问题,而有机基提供有限的成像持续时间.
研究的目的:
- 开发一种新的,稳定的,有针对性的MRI对比剂,克服现有配方的局限性.
- 设计一个2D黑色纳米平台,用于增强和延长心血管成像.
主要方法:
- 原子尺度上的氨基铁与二维黑的结合,形成FcP.
- 氨酸功能化用于CD44特定向 (HA-FcP).
- 在阿波利波蛋白E缺陷模型中的体内评估,用于斑块积累和病变可视化.
主要成果:
- 由于共价合,FcP表现出持续的T2加权对比能力.
- 与非向剂相比,HA-FcP的斑块积累率是非向剂的1.7倍.
- 在注射后120小时实现了动脉样硬化病变的连续MRI可视化,细胞活力>90%.
结论:
- 激进设计的2D BP纳米平台 (FcP) 提供了稳定有效的MRI对比剂.
- 特定于CD44的向增强了斑块积累和诊断成像持续时间.
- 这种方法开创了新一代MRI对比剂,用于精确的心血管诊断.
相关概念视频
01:24Magnetic Resonance Imaging
Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...
01:21Imaging Studies for Cardiovascular System IV: CMRI
Cardiovascular magnetic resonance imaging, or CMRI, is a non-invasive diagnostic test that employs a magnetic field and radiofrequency waves to create precise images of the heart and arteries. It provides comprehensive information about cardiac anatomy, function, perfusion, and tissue characterization without ionizing radiation.IndicationsCMRI diagnoses various heart conditions, including tissue damage from heart attacks, ischemic heart disease, myocarditis, aortic issues (tears, aneurysms,...